Abiopharma

🔍 McNeice Paul Francis (Executive)

Company: American Well Corp (AMWL)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Sold 384 shares of Class A Common Stock at $4.85 per share (Direct)
  Date: 2026-01-02 | Code: S | equity_swap_involved: false | shares_owned_after: 3,063.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on January 1, 2026. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.